Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
02 Maggio 2024 - 3:00PM
Business Wire
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the
“Company”) will report its first quarter 2024 financial results on
Thursday, May 9, 2024. Amylyx’ senior management team will host a
conference call and audio webcast at 8:00 a.m. ET to discuss the
financial results and other company updates.
To access the conference call, please dial +1 (877)-346-6112
(U.S. & Canada) or +1 (848)-280-6350 (international) at least
10 minutes prior to the start time and ask to be joined into the
Amylyx Pharmaceuticals call. A live audio webcast of the call will
be available under “Events and Presentations” in the Investor
section of the Company’s website,
https://investors.amylyx.com/news-events/events. The webcast will
be archived and available for replay for 90 days following the
event.
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is committed to supporting and
creating more moments for the neurodegenerative disease community
through the discovery and development of innovative new treatments.
Amylyx is headquartered in Cambridge, Massachusetts. For more
information, visit amylyx.com and follow us on LinkedIn and X,
formerly known as Twitter. For investors, please visit
investors.amylyx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240502818836/en/
Media Amylyx Media Team +1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors Lindsey Allen Amylyx Pharmaceuticals, Inc. +1 (857)
320-6244 Investors@amylyx.com
Grafico Azioni Amylyx Pharmaceuticals (NASDAQ:AMLX)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Amylyx Pharmaceuticals (NASDAQ:AMLX)
Storico
Da Gen 2024 a Gen 2025
